The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,053,291 in first-year total cost, median $1,420,775.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-A (18)]3
Most frequent institutions
- UNIVERSITY OF ROCHESTER2
- CHILDREN'S HOSP OF PHILADELPHIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Clinical Outcomes in Aicardi Goutières Syndrome1U01NS106845-01A1 | VANDERVER, ADELINE LUCIE | CHILDREN'S HOSP OF PHILADELPHIA, PA | $1,867,066 | ZNS1 |
| 2019 | Accelerate Clinical Trials in CMT (ACTCMT) Study1U01NS109403-01 | HERRMANN, DAVID N | UNIVERSITY OF ROCHESTER, NY | $1,420,775 | ZNS1 |
| 2019 | Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis1U01NS101946-01A1 | AUGUSTINE, ERIKA | UNIVERSITY OF ROCHESTER, NY | $765,450 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.